인공지능(AI) 기반 의약품 안전성 및 약물감시 플랫폼 시장 보고서(2026년)

Artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms are software-enabled systems that utilize machine learning, natural language processing, and data analytics to identify, evaluate, monitor, and prevent adverse drug reactions and other pharmaceutical safety concerns. These platforms analyze extensive clinical, real-world, and regulatory datasets to enhance signal detection, automate safety reporting, and ensure regulatory compliance throughout the entire drug development and commercialization lifecycle.

The primary components of artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms include software platforms and services. Software platforms refer to AI-enabled solutions that automate the collection, analysis, monitoring, and reporting of adverse drug events to strengthen drug safety and ensure regulatory compliance. These platforms are deployed through cloud-based, on-premise, and hybrid models and are adopted by large enterprises and small and medium-sized enterprises. The various applications include case processing and management, signal detection and management, risk management and reporting, and regulatory compliance, and they are used by several end users such as pharmaceutical companies, biotechnology companies, contract research organizations, regulatory authorities, healthcare providers, and academic and research institutes.

Tariffs are influencing the artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market by increasing the cost of imported cloud infrastructure, high-performance computing systems, and advanced data analytics tools required for large-scale safety monitoring. This is slowing the deployment of pharmacovigilance solutions, particularly in Asia-Pacific and Europe, where pharmaceutical data ecosystems rely heavily on global technology imports. Software platforms and regulatory compliance systems are most affected due to their dependency on cross-border data infrastructure and integration tools. However, tariffs are also encouraging localized healthcare data infrastructure development, regional cloud investments, and stronger domestic regulatory technology ecosystems, ultimately improving data sovereignty and compliance resilience.

The artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market size has grown exponentially in recent years. It will grow from $2.14 billion in 2025 to $2.59 billion in 2026 at a compound annual growth rate (CAGR) of 20.6%. The growth in the historic period can be attributed to rise in global adverse drug reaction reporting requirements, increasing digitization of clinical trial data, expansion of pharmacovigilance regulatory frameworks, growth in pharmaceutical research activity, adoption of electronic health records in healthcare systems.

The artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market size is expected to see exponential growth in the next few years. It will grow to $5.39 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to integration of ai into drug safety surveillance systems, expansion of real-world evidence based pharmacovigilance, increasing regulatory demand for automated compliance reporting, growth in predictive safety analytics platforms, rising adoption of cloud-based drug safety monitoring systems. Major trends in the forecast period include AI-powered adverse event detection systems, natural language processing based safety signal extraction, predictive pharmacovigilance analytics platforms, real-time drug safety monitoring using real-world data, automated regulatory safety reporting systems.

The increasing volume of adverse event (AE) reports is expected to propel the growth of the artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market going forward. Adverse event (AE) reports refer to documented cases of unintended and harmful reactions or outcomes experienced after the use of a medical product or drug. The volume of adverse event (AE) reports is increasing due to stricter regulatory requirements that require healthcare providers and pharmaceutical companies to report a broader range of safety issues more frequently and in greater detail. Artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms process adverse event (AE) reports by aggregating data from clinical systems, electronic health records, and real-world sources to detect and classify safety signals, automate case processing, and improve the speed and accuracy of regulatory decision-making. For instance, in February 2024, according to the Analysis of Adverse Drug Reactions 2023 Report by the Department of Health Abu Dhabi, a UAE-based regulatory body, a total of 1,522 adverse drug reaction reports were submitted to the pharmacovigilance program between January and December 2023, representing a 235% increase compared to the average annual number of reports recorded in previous years. Therefore, the increasing volume of adverse event (AE) reports is driving the growth of the artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market.

Key companies operating in the artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market are focusing on developing innovative treatments, such as agentic AI-driven pharmacovigilance platforms, to enhance automated adverse event detection, regulatory compliance, and efficiency in drug safety monitoring by reducing manual case-processing workloads and improving signal detection accuracy. Agentic AI pharmacovigilance platforms are advanced software systems that use domain-trained machine learning models, natural language processing, and workflow orchestration to independently perform and coordinate safety tasks such as case intake, literature surveillance, signal detection, and aggregate reporting. For example, in May 2026, RxLogix Systems Inc., a US-based pharmacovigilance solutions company, launched the upgraded PVOne.AI platform, an AI-enabled pharmacovigilance system that integrates agentic AI capabilities to automate and orchestrate end-to-end drug safety workflows. The platform operates across case intake, adverse event monitoring, literature surveillance, signal detection, aggregate reporting, and risk management, leveraging contextual reasoning and domain-trained models to support regulatory-grade decision-making. It also includes human-in-the-loop controls to ensure compliance with FDA and global pharmacovigilance standards while significantly reducing manual effort in case processing by up to 80%, improving reviewer productivity by up to 75%, and enabling up to 50% touchless workflows by minimizing repetitive tasks and enhancing prioritization of safety signals in large-scale pharmaceutical datasets.

In October 2024, EVERSANA Inc., a US-based pharmaceutical manufacturing company specializing in providing comprehensive AI-driven platforms and solutions for drug safety and pharmacovigilance (PV), partnered with Oracle Corporation to enhance pharmacovigilance and drug safety capabilities. Through this partnership, EVERSANA Inc. entered into a strategic collaboration agreement with Oracle Corporation to implement Oracle Argus Cloud Service, enabling AI-powered automation, workflow optimization, and touchless processing to improve safety case management, regulatory compliance, and global patient support services across the life sciences industry. Oracle Corporation is a US-based technology company specializing in cloud infrastructure, enterprise software, and healthcare and life sciences solutions.

Major companies operating in the artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market are Microsoft Corporation; International Business Machines Corporation; Accenture plc; Oracle Corporation; Cognizant Technology Solutions Corporation; IQVIA Holdings Inc.; Wipro Limited; ICON Public Limited Company; Fortrea; Clarivate Plc; Genpact Limited; Veeva Systems Inc.; ArisGlobal; Certara Inc.; Tempus AI Inc.; Komodo Health Inc.; Elsevier B.V.; Navitas Life Sciences; PrimeVigilance; Ennov Group SAS; Cloudbyz Inc.; Phesi; Medrio Inc.; Genomics England Limited

North America was the largest region in the artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market includes revenues earned by entities by providing services such as software licensing and subscription, cloud-based pharmacovigilance solutions, adverse event detection and reporting systems, data integration and interoperability solutions, predictive safety analytics, regulatory compliance support, system customization and integration, maintenance and technical support, consulting, and training services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market statistics, including artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms industry global market size, regional shares, competitors with a artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market share, detailed artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms industry. This artificial intelligence (AI)-driven drug safety and pharmacovigilance platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai)-driven drug safety and pharmacovigilance platforms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-driven drug safety and pharmacovigilance platforms ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-driven drug safety and pharmacovigilance platforms market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Software Platforms; Services
• 2) By Deployment Mode: Cloud-Based; On-Premise; Hybrid
• 3) By Enterprise Size: Large Enterprises; Small And Medium-Sized Enterprises
• 4) By Application: Case Processing And Management; Signal Detection And Management; Risk Management And Reporting; Regulatory Compliance
• 5) By End User: Pharmaceutical Companies; Biotechnology Companies; Contract Research Organizations; Regulatory Authorities; Healthcare Providers; Academic And Research Institutes
• Subsegments:
• 1) By Software Platforms: Adverse Event Monitoring Software Platforms; Natural Language Processing Based Pharmacovigilance Platforms; Predictive Analytics And Safety Intelligence Platforms
• 2) By Services: Implementation And Integration Services; Consulting And Regulatory Compliance Services; Artificial Intelligence Model Training And Validation Services; Maintenance And Support Services
• Companies Mentioned: Microsoft Corporation; International Business Machines Corporation; Accenture plc; Oracle Corporation; Cognizant Technology Solutions Corporation; IQVIA Holdings Inc.; Wipro Limited; ICON Public Limited Company; Fortrea; Clarivate Plc; Genpact Limited; Veeva Systems Inc.; ArisGlobal; Certara Inc.; Tempus AI Inc.; Komodo Health Inc.; Elsevier B.V.; Navitas Life Sciences; PrimeVigilance; Ennov Group SAS; Cloudbyz Inc.; Phesi; Medrio Inc.; Genomics England Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Fintech, Blockchain, Regtech & Digital Finance
  • 4.1.5 Internet Of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 AI-Powered Adverse Event Detection Systems
  • 4.2.2 Natural Language Processing Based Safety Signal Extraction
  • 4.2.3 Predictive Pharmacovigilance Analytics Platforms
  • 4.2.4 Real-Time Drug Safety Monitoring Using Real-World Data
  • 4.2.5 Automated Regulatory Safety Reporting Systems

5. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Contract Research Organizations
• 5.4 Regulatory Authorities
• 5.5 Healthcare Providers And Academic And Research Institutes

6. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Segmentation

• 9.1. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Software Platforms, Services
• 9.2. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cloud-Based, On-Premise, Hybrid
• 9.3. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Large Enterprises, Small And Medium-Sized Enterprises
• 9.4. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Case Processing And Management, Signal Detection And Management, Risk Management And Reporting, Regulatory Compliance
• 9.5. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Regulatory Authorities, Healthcare Providers, Academic And Research Institutes
• 9.6. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Sub-Segmentation Of Software Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adverse Event Monitoring Software Platforms, Natural Language Processing Based Pharmacovigilance Platforms, Predictive Analytics And Safety Intelligence Platforms
• 9.7. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Implementation And Integration Services, Consulting And Regulatory Compliance Services, Artificial Intelligence Model Training And Validation Services, Maintenance And Support Services

10. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Industry Metrics By Country

• 10.1. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
• 10.2. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Regional And Country Analysis

• 11.1. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 11.2. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 12.1. Asia-Pacific Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. Asia-Pacific Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 13.1. China Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 13.2. China Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 14.1. India Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 15.1. Japan Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 15.2. Japan Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 16.1. Australia Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 17.1. Indonesia Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 18.1. South Korea Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. South Korea Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 19.1. Taiwan Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. Taiwan Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 20.1. South East Asia Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. South East Asia Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 21.1. Western Europe Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 21.2. Western Europe Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 22.1. UK Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 23.1. Germany Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 24.1. France Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 25.1. Italy Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 26.1. Spain Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 27.1. Eastern Europe Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 27.2. Eastern Europe Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 28.1. Russia Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 29.1. North America Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. North America Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 30.1. USA Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. USA Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 31.1. Canada Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. Canada Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 32.1. South America Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 32.2. South America Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 33.1. Brazil Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 34.1. Middle East Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Middle East Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

• 35.1. Africa Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 35.2. Africa Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market, Segmentation By Component, Segmentation By Deployment Mode, Segmentation By Enterprise Size, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Regulatory and Investment Landscape

37. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Competitive Landscape And Company Profiles

• 37.1. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Competitive Landscape And Market Share 2024
  • 37.1.1. Top 10 Companies (Ranked by revenue/share)
• 37.2. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market - Company Scoring Matrix
  • 37.2.1. Market Revenues
  • 37.2.2. Product Innovation Score
  • 37.2.3. Brand Recognition
• 37.3. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Company Profiles
  • 37.3.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.2. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.3. Accenture plc Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.4. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 37.3.5. Cognizant Technology Solutions Corporation Overview, Products and Services, Strategy and Financial Analysis

38. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Other Major And Innovative Companies

• IQVIA Holdings Inc., Wipro Limited, ICON Public Limited Company, Fortrea, Clarivate Plc, Genpact Limited, Veeva Systems Inc., ArisGlobal, Certara Inc., Tempus AI Inc., Komodo Health Inc., Elsevier B.V., Navitas Life Sciences, PrimeVigilance, Ennov Group SAS

39. Global Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market Competitive Benchmarking And Dashboard

40. Upcoming Startups in the Market

41. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market

42. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market High Potential Countries, Segments and Strategies

• 42.1. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market In 2030 - Countries Offering Most New Opportunities
• 42.2. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market In 2030 - Segments Offering Most New Opportunities
• 42.3. Artificial Intelligence (AI)-Driven Drug Safety And Pharmacovigilance Platforms Market In 2030 - Growth Strategies
  • 42.3.1. Market Trend Based Strategies
  • 42.3.2. Competitor Strategies

43. Appendix

• 43.1. Abbreviations
• 43.2. Currencies
• 43.3. Historic And Forecast Inflation Rates
• 43.4. Research Inquiries
• 43.5. The Business Research Company
• 43.6. Copyright And Disclaimer